American Healthcare REIT Inc’s filing revealed that its Director Hanson Jeffrey T unloaded Company’s shares for reported $1.72 million on Dec 22 ’25. In the deal valued at $48.38 per share,35,570 shares were sold. As a result of this transaction, Hanson Jeffrey T now holds 19,208 shares worth roughly $0.92 million.
Then, Hanson Jeffrey T sold 19,208 shares, generating $929,690 in total proceeds. Upon selling the shares at $48.40, the Director now owns 0 shares.
Before that, Jeffrey Hanson bought 54,778 shares. American Healthcare REIT Inc shares valued at $2,649,904 were divested by the Director at a price of $48.38 per share.
UBS initiated its American Healthcare REIT Inc [AHR] rating to a Buy in a research note published on September 19, 2025; the price target was $51. A number of analysts have revised their coverage, including Robert W. Baird’s analysts, who began to cover the stock in mid July with a ‘”an Outperform”‘ rating. Scotiabank began covering AHR with “Sector outperform” recommendation on June 30, 2025. Jefferies started covering the stock on April 28, 2025. It rated AHR as “a Buy”.
Price Performance Review of AHR
On Tuesday, American Healthcare REIT Inc [NYSE:AHR] saw its stock fall -1.16% to $47.74. Over the last five days, the stock has lost -1.57%. American Healthcare REIT Inc shares have risen nearly 66.75% since the year began. Nevertheless, the stocks have risen 67.98% over the past one year. While a 52-week high of $51.01 was reached on 12/04/25, a 52-week low of $26.40 was recorded on 01/13/25.
Levels Of Support And Resistance For AHR Stock
The 24-hour chart illustrates a support level at 47.39, which if violated will result in even more drops to 47.04. On the upside, there is a resistance level at 48.28. A further resistance level may holdings at 48.82.
How much short interest is there in American Healthcare REIT Inc?
A steep rise in short interest was recorded in American Healthcare REIT Inc stocks on 2025-12-15, growing by 11.78 million shares to a total of 14.92 million shares. Yahoo Finance data shows the prior-month short interest on 2025-11-14 was 3.14 million shares. There was a rise of 78.95%, which implies that there is a positive sentiment for the stock.
The most recent change occurred on March 14, 2024 when Barclays began covering the stock and recommended ‘”an Overweight”‘ rating along with a $18 price target.
